The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials

Ika Rahayu ^1,2 , Nur Arfian ^3,4 * , Christina Yeni Kustanti ^5,6 , Mae Sri Hartati Wahyuningsih ^4,7

Cited by CrossRef: 4

1- Tian Y, Wu X, Gong Z, Liang X, Zhu H, Zhang J, Hu Y, Li B, Xu P, Guo K, Yue H. Ozone Exposure Induces Prediabetic Symptoms Through Hepatic Glycogen Metabolism and Insulin Resistance. Toxics. 2025;13(8):652 [Crossref]

2- Mangarov I, Voynikov Y, Petkova V, Iliev S, Kostadinova I, Marinov L, Nikolova I. Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound. CIMB. 2025;47(6):402 [Crossref]

3- Guerrero-Mauvecin J, Villar-Gómez N, Miño-Izquierdo L, Povo-Retana A, Ramos A, Ruiz-Hurtado G, Sanchez-Niño M, Ortiz A, Sanz A. Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome. Antioxidants. 2025;14(6):701 [Crossref]

4- Matsui T, Sotokawauchi A, Nishino Y, Koga Y, Yamagishi S. Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis. IJMS. 2025;26(7):3007 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons